Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
PARENTERAL DRUGS (INDIA) LTD. - Board Meeting Intimation for Consideration Of The Annual Audited Financial Results For The Fourth Quarter And Financial Year 2021-22 Ended On 31St March, 2022.
Download announcement < Back
18 May 2022
PARENTERAL DRUGS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve 1. The Annual Audited Financial Results of the Company (on Standalone and Consolidated basis) for the fourth quarter and the Financial Year 2021-22 ended on 31st March, 2022. 2. The shifting of registered office of the Company within local limits of the city where it is presently situated from 340, Laxmi Plaza, Laxmi Industrial Estate, New Link Road, Andheri (West) Mumbai -400053 (Maharashtra) to E/210, 2nd Floor, Crystal Plaza, Off New Link Road, Andheri West, Mumbai -400053 (Maharashtra) and other items as per agenda of the meeting.
View all announcements for PARENTERAL DRUGS (INDIA) LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips